Endocrine News Podcast · Endocrine Society

ENP105: Tirzepatide and Menopause

October 29, 2025·19 min·1 clip

The study found women on hormone therapy lost 19% body weight with tirzepatide versus 14% without, a 35% greater weight loss.

This episode of the Endocrine News Podcast features researchers Dr. Daniela Hurtado-Andrade and Dr. Regina Castaneda discussing their study on weight loss outcomes with the medication tirzepatide in postmenopausal women. They explore the connection between menopause, hormone therapy, and body composition, presenting findings that suggest a synergistic effect while emphasizing the need for individualized patient care and further research.

As heard by us

A measured look at menopausal weight change and what terzepatide may offer.

The episode keeps its focus on menopause-related weight gain and whether terzepatide may help postmenopausal women dealing with changes in body composition and related health concerns. Dr. Daniela Hurtado-Andrade and Dr.

Read the full review in PlayNext →

Why you'd press play

Wondering whether tirzepatide could matter in the postmenopause weight-loss conversation?

Read the full recommendation in PlayNext →

Listen to the show on

Apple Podcasts Spotify

Play clips from this episode More from Endocrine News Podcast